Ranitidine
Zantac (ranitidine) is a small molecule pharmaceutical. Ranitidine was first approved as Zantac on 1983-06-09. It is used to treat duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, and zollinger-ellison syndrome in the USA. The pharmaceutical is active against histamine H2 receptor.
| Trade Name | Zantac |
|---|---|
| Common Name | Ranitidine |
| Indication | duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, zollinger-ellison syndrome |
| Drug Class | H2-receptor antagonists (cimetidine type) |
